Anti-Chymase Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the catalytic domain of human Chymase (CMA1), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
P23946
Size
100ug
Cat. #
RP2Chymase

In stock

SKU
RP-Chymase

Options

As low as: $130.00

Target Overview

Chymase (CMA1, UniProt P23946; EC 3.4.21.39) is a 247-residue chymotrypsin-like serine protease secreted primarily by mast cells. It functions as the major secreted protease in these cells and plays roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion. Chymase cleaves angiotensin I to generate angiotensin II independently of angiotensin-converting enzyme, and degrades extracellular matrix components including fibronectin and type IV collagen. The enzyme is stored in secretory granules and released upon mast cell degranulation. Researchers study Chymase in the context of cardiovascular remodeling, fibrotic disease, allergic inflammation, and tissue repair processes. Its restricted expression pattern and potent proteolytic activity make it a marker of mast cell activation and a target for understanding mast cell-mediated pathology.

Background

Chymase belongs to the peptidase S1 family and is encoded by CMA1 on chromosome 14q12. The protein is synthesized as a zymogen and activated within mast cell granules, where it is stabilized by heparin proteoglycans. Beyond its role in angiotensin II formation, Chymase cleaves a variety of bioactive substrates including big endothelin-1, substance P, and vasoactive intestinal peptide, implicating it in both vasoconstriction and neuropeptide processing. Its matrix-degrading activity contributes to tissue remodeling in conditions such as cardiac fibrosis, pulmonary fibrosis, and vascular aneurysm formation. Recent degradomics work has identified Chymase alongside MMP9 as a key protease in the proteolytic landscape of aortic aneurysms, where it contributes to extracellular matrix turnover and vascular wall weakening (Bhutada et al., 2026). Chymase expression is elevated in fibrotic tissues and inflammatory lesions, and its activity has been linked to aberrant wound healing. In hereditary gingival fibromatosis, Chymase deficiency has been shown to drive pathological fibroblast activation, a phenotype that can be attenuated by exosome-based therapeutic intervention (Chen et al., 2026). The enzyme is also implicated in neuroinflammatory contexts, where mast cell infiltration and protease release contribute to microglial activation and tissue damage. Chymase-specific inhibitors are under investigation as potential therapeutics for heart failure, asthma, and fibroproliferative disorders. The enzyme's restricted tissue distribution and substrate specificity make it a valuable biomarker for mast cell involvement in disease. Triple Point Biologics offers two rabbit polyclonal antibodies raised against the catalytic domain of human Chymase, validated for Western blot applications. These reagents are suited for detecting endogenous Chymase in tissue sections and cell lysates, supporting studies of mast cell biology and protease-mediated remodeling.

References

  1. Bhutada S et al (2026) Integrated Forward and Reverse Degradomics of Aortic Aneurysms Uncovers Their Proteolytic Landscapes and the Roles of MMP9 and Mast Cell Chymase. Arterioscler Thromb Vasc Biol. PubMed · DOI
  2. Chen X et al (2026) Non-Syndromic Hereditary Gingival Fibromatosis Driven by Chymase Deficiency Is Attenuated by Verteporfin-Loaded Exosomes. J Clin Periodontol. PubMed · DOI

Additional Specifications

Size 100 µg
Gene Symbol CMA1
UniProt ID P23946
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 22-247.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 197-247.
Alternate Names CMA1, Alpha-chymase, Mast cell protease I, EC 3.4.21.39, Mast cell protease 1

Frequently Asked Questions

What molecular weight should I expect for Chymase on a Western blot?

Chymase (CMA1) migrates at approximately 30 kDa on reducing SDS-PAGE, corresponding to the mature secreted form after signal peptide cleavage. The full-length precursor is 247 residues, but the 26-residue N-terminal signal sequence is removed during secretion from mast cells. Some samples may show minor higher-molecular-weight bands around 37 kDa representing glycosylated forms or incompletely processed enzyme. If working with mast cell lysates or granule preparations, the 30 kDa band should be prominent. Recombinant Chymase standards typically run at the same 30 kDa position.

What starting dilution should I use for Chymase Western blots?

Start at 1:1000 dilution for Western blot with this rabbit polyclonal antibody, as recommended from our validation data. Optimal dilution depends on Chymase expression level in your sample; mast cell-rich tissues like skin, lung, or heart will yield strong signal at 1:1000, while samples with sparse mast cell populations may require 1:500. Incubate overnight at 4°C for best results. If background is high, titrate up to 1:2000. Always include a positive control lysate from human mast cell lines (HMC-1, LAD2) or mast cell-enriched tissue to confirm antibody performance.

Does this antibody cross-react with other chymotryptic proteases like cathepsin G or mast cell tryptase?

Chymase shares structural similarity with other serine proteases, but this antibody was raised against Chymase-specific epitopes. We have not observed cross-reactivity with cathepsin G (approximately 29 kDa) or mast cell tryptase (approximately 35 kDa) in validated human samples. However, because multiple chymotrypsin-fold proteases exist in mast cell granules, we recommend running positive controls for Chymase alongside your experimental samples. If you observe unexpected bands, consider siRNA knockdown or comparison with Chymase-deficient cell lines to confirm specificity in your particular tissue context.

Will this antibody work with mouse or rat samples?

This antibody is validated for human Chymase (CMA1). Reactivity with mouse or rat Chymase is not validated. Mouse expresses multiple mast cell chymases (mMCP-1, -2, -4, -5, -9) with varying homology to human CMA1, and rats express rMCP-1, -2, and -5. Sequence identity between human CMA1 and rodent orthologs ranges from 65-75 percent, so cross-reactivity is possible but not assured. If you need to work with rodent samples, we recommend testing at multiple dilutions with species-appropriate positive controls or considering a rodent-specific Chymase antibody.

What positive control tissue should I use for Chymase immunohistochemistry?

Human skin, lung parenchyma, or myocardium provide reliable positive controls for Chymase IHC because these tissues contain abundant resident mast cells. In normal skin, Chymase-positive mast cells appear in the papillary and reticular dermis with characteristic cytoplasmic granular staining. Tonsil and gastrointestinal mucosa also work well. For disease models, fibrotic tissue or sites of allergic inflammation show elevated mast cell numbers. Perform antigen retrieval with citrate buffer (pH 6.0) for formalin-fixed paraffin-embedded sections. Negative controls should include Chymase-poor tissues like skeletal muscle or omission of primary antibody.

Should I add protease inhibitors when preparing lysates for Chymase Western blot?

Yes, include a broad-spectrum protease inhibitor cocktail when lysing cells or tissues for Chymase detection. Chymase itself is a potent serine protease, and upon cell lysis it can be released from secretory granules and potentially degrade other proteins or undergo autocatalytic processing. Standard serine protease inhibitors like PMSF or AEBSF are advisable, though they may not completely inhibit Chymase activity at typical concentrations. Work quickly on ice, and snap-freeze aliquots to minimize degradation. Avoid repeated freeze-thaw cycles, which can disrupt mast cell granules and release active enzyme into the lysate.

How should I store this Chymase antibody and what is the shelf life?

Store the antibody at -20°C in the supplied buffer. As a rabbit polyclonal, it remains stable for at least one year under these conditions. Avoid repeated freeze-thaw cycles by making single-use aliquots upon receipt; 5-10 µL aliquots work well for most Western blot experiments given the 1:1000 recommended dilution. If you need to store diluted antibody, add 0.02 percent sodium azide and keep at 4°C for up to one month, though we generally recommend preparing fresh working dilutions. Do not store diluted antibody without preservative, as bacterial contamination will degrade immunoglobulin over time.

Can I detect secreted Chymase in cell culture supernatants or is it only intracellular?

Chymase is stored in mast cell secretory granules and released upon degranulation, so it can be detected in culture supernatants after appropriate stimulation. Treat mast cells with calcium ionophore (A23187), IgE cross-linking, or compound 48/80 to trigger degranulation, then collect supernatants after 30-60 minutes. Concentrate supernatants 10-20 fold using centrifugal filters (10 kDa cutoff) before Western blot, as secreted concentrations may be low. Note that released Chymase retains enzymatic activity and may degrade matrix proteins in serum-containing media; work quickly and add protease inhibitors to supernatants immediately after collection.

Validation imagery coming soon

Western blot validation figures for RP-Chymase will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • CMA1
  • Alpha-chymase
  • Mast cell protease I
  • EC 3.4.21.39
  • Mast cell protease 1
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →